杂志简称：inflamm bowel dis
中文译名：《炎症性肠病》
收录属性：高质量科技期刊（t3）, scie（2024版）, 目次收录（维普）,英文期刊,
自引率：6.10%
投稿方向：医学、gastroenterology & hepatology 胃肠肝病学
SCI/E期刊基本信息
出版周期：月刊 地区：美国
中科院分区：2区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN1078-0998；EISSN1536-4844
杂志语言：英语
出版国家：美国
杂志官网 联系方式
出版地址：JOHN WILEY & SONS INC,111 RIVER ST,HOBOKEN,USA,NJ,07030
杂志邮箱：
投稿网址：http://www.editorialmanager.com/ibd
杂志官方网址：https://academic.oup.com/ibdjournal
出版商网址：http://www.oxfordjournals.org
杂志投稿要求
投稿须知【杂志社官方网站信息】
Inflammatory Bowel Diseases
Instructions to Authors
Scope
General Submission Information
Ethical Considerations
Authorship, Plagiarism, Patient Consent, Human/Animal Studies, Clinical Trials Registration, Conflict of Interest
Guidelines by Article Type
Review Articles, Original Articles, Future Directions and Methods, Letters, Commentaries
Preparation of Manuscript
Title Page, Abstract, Keywords, Abbreviations, Style, References, Figures, Tables, Supplementary Data, Permissions, Availability of Data and materials, Data Citation
Following Submission/Acceptance
Revisions, Exclusive License, Page Proofs and Corrections, Funding Compliance, Using IBD Reviews
Open Access
Scope
Inflammatory Bowel Diseases® (IBD) supports the mission of the Crohn's & Colitis Foundation by bringing the most impactful and cutting edge clinical topics and research findings related to inflammatory bowel diseases to clinicians and researchers working in IBD and related fields. The Journal is committed to publishing on innovative topics that influence the future of clinical care, treatment, and research. The Journal publishes peer-reviewed manuscripts and review articles in basic and clinical sciences, updates on clinical trials, reviews of the current literature, editorials, and other features.
General Submission Information
All manuscripts must be submitted through the Journal's online submission system. For questions on preparing manuscripts for submission to IBD, please contact ibd.editorialoffice@jjeditorial.com.
IBD complies with International Committee of Medical Journal Editors’ Uniform Requirements for Manuscripts. Authors should observe high standards with respect to publication ethics as set out by the Committee on Publication Ethics (COPE).
Presubmission Language Editing
If you are not confident in the quality of your English, you may wish to use a language-editing service to ensure that editors and reviewers understand your paper. Oxford University Press partners with Enago, a leading provider of author services. Prospective authors are entitled to a discount of 30% for editing services at Enago, via the Specialist English Editing Services for Oxford University Press Authors page.
Enago is an independent service provider, who will handle all aspects of this service, including payment. As an author you are under no obligation to take up this offer. Language editing is optional and does not guarantee that your manuscript will be accepted. Edited manuscripts will still undergo peer review by the journal.
Graphical and Video Abstracts
Authors are encouraged to submit a graphical abstract and/or video abstract as part of the article, in addition to the text abstract. A template for graphical abstracts can be found here. The graphical/video abstract should clearly summarize the focus and findings of the article, and will be published as part of the article online and in PDF. The graphical/video abstract should be submitted for peer review as a separate file, selecting the appropriate file-type designation in the journal’s online submission system. The file should be clearly named, e.g. graphical-abstract.tiff, video-abstract.mp4. See more manuscript resources for guidance on appropriate file format and resolution for graphics and videos. Video abstracts must be provided in mp4 files and graphical abstracts must be provided in tiff files with a resolution of 300 dpi or higher. Please ensure graphical abstracts are in landscape format.
Ethical Considerations
A submitted manuscript must be an original contribution not previously published (except as an abstract or preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of the publisher. Deposition of manuscripts prior to submission on community preprint servers or on conference presentations online will not be considered prior publication and will not compromise potential publication in IBD. In the Editorial Manager submission process, authors are asked to disclose that the manuscript has been posted to a preprint server along with a link to the paper. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher.
Authorship
Each person listed as an author is expected to follow the authorship criteria put forth by the ICMJE. Deceased persons who meet the criteria for inclusion as coauthors should be so included, with an Author Information note indicating the date of death.
In submitting to IBD, authors are expected to honor all deadlines presented to them. Authors are expected to respond to all communication from the Editorial staff in a timely manner and should inform the Editorial staff promptly if they require an extension to complete their paper or if any unforeseen events prohibit them from writing their paper. The Journal reserves the right to not publish a paper if an author fails to meet their assigned deadlines or if the paper does not meet the Journal’s standards of quality.
Plagiarism
All papers must be free of plagiarism. Plagiarism includes the unreferenced use of the author’s own work or ideas or the work or ideas of others, either published or unpublished. It may occur at any stage of the development of a manuscript and it applies to print and electronic versions of the work. Authors should consult the Committee on Publication Ethics’ (COPE) Guidelines on Good Publication Practice if they have questions about reuse of others’ work.
The Editorial staff may subject submitted manuscripts to analysis using the iThenticate software program. If plagiarism is identified, the Editorial staff will request corrections or clarification from the author.
When a case of plagiarism is confirmed after publication, the Journal will publish a notice in a subsequent issue and possibly take further action according to Committee on Publication Ethics guidelines. Authors who have been found to be guilty of plagiarism after the appropriate institutional investigation will be banned from submitting to the Journal for a defined period of time.
Patient Anonymity and Informed Consent
It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should mask patients' eyes and remove patients' names from figures unless they obtain written consent from the patients and submit written consent with the manuscript. Please use the Patient Consent Form.
Human Studies
Human experimentation must conform to ethical standards, and be approved by the appropriate Institutional Review Board (IRB). A statement concerning IRB approval and consent procedures must appear at the beginning of the Methods section. Any systematic data gathering effort in patients or volunteers must be approved by an IRB or adhere to appropriate local/national regulations. The Editors of IBD take IRB review and informed consent very seriously. Authors may be questioned about the details of consent forms or the consent process. On occasion, the Editors may request a copy of the approved IRB application from the author. Lack of appropriate consent or documentation may be grounds for rejection. Local IRB approval does not guarantee acceptability; the final decision will be made by the Editors.
Manuscripts that reveal the identity of any patient through figures, video, or audio files must be accompanied by written permission statement/release form signed by the identified adult or minor. The author may download and utilize using the links above.
Animal Studies
Experimental work on animals must conform to the guidelines laid out in the Guide for the Care and Use of Laboratory Animals, which is available from the National Academy of Science; a text-only version is available to download as a pdf. Adherence to all relevant regulations and/or approval of the appropriate institutional Animal Care Committee or governmental licensure of the investigator and/or laboratory must be obtained. A statement concerning such approval must be included at the beginning of the Methods section. The Editors of IBD are concerned about appropriate animal care. On occasion, the Editors may request a copy of the approved Animal Care Committee application from the author. Local committee approval does not guarantee acceptability; the final decision will be made by the handling Editor.
Registration of Clinical Trials
All clinical trials that involve investigational drugs supported by a pharmaceutical firm or investigational devices supported by a device manufacturer must be registered at the time that a manuscript is submitted to IBD for publication. The registry and registration number must be stated in the first paragraph of the Methods section of the manuscript.
Policies on Conflicts of Interest
IBD is committed to making transparent the Journal’s policies on Conflict of Interest as they relate to authors, reviewers, and editors. Authors should familiarize themselves with the below points as well as COPE’s Guidelines on Good Publication Practice before committing to working with the Journal.
Conflicts in regard to publication can occur when a competing interest may influence or be perceived to influence the judgment of author, reviewers, and editors. Conflicts of interest are considered relationships within three years prior to the authoring, reviewing, or editing of the given manuscript. Specifically, these relationships may include:
Employment (including employment by the same institution)
Mentoring
Collaborating
Research funding
Consultancies
Honoraria
Stock or share ownership
Grants received and pending
Royalties
Company support for staff
Commercial interests
Political or religious views
Any other close personal relationship
Author Conflict of Interest
As part of the Editorial Manager submission process, authors are required to declare all potential conflicting interests — financial, personal, or otherwise — that might be perceived as influencing the information presented in their manuscript. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be disclosed during the submission process in Editorial Manager and should be listed on the title page as well.
When in doubt, authors should seek advice from the Editors if they are unsure whether something constitutes a relevant conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared.
In the event that a potential conflict of interest is apparent or suspected, the Journal Editorial staff will request clarification from the author. In the event that a conflict was not disclosed, the Journal may publish a notice in a subsequent issue and possibly take further action according to COPE guidelines.
Clinical Practice Guidelines
All clinical practice guidelines submitted for publication in IBD must adhere to the recommendations set forth by the National Academy of Medicine. Their recommendations include appointing committee chairs with no financial conflicts of interest and limiting guideline authors with financial conflicts of interest to less than 50% of the panel. Further detail on the recommendations can be found on the NCBI website.
Guidelines by Article Type
Basic and clinical articles submitted to IBD should be submitted as either Review Articles or Original Articles using the parameters below. Following acceptance of an article, it may be designated to publish under a featured designation such as Future Directions and Methods, both of which are described in the following section.
Review Articles
Review Articles should be classified as either Basic Science or Clinical and should present recent advances in a relatively narrow topic that have been made in cutting edge research. Review articles should present a complete summary of important research areas that are now improving our understanding of Crohn's disease and ulcerative colitis. All Review Articles will be peer-reviewed. Pre-submission inquiries to the Editors in Chief on the suitability of topics for Review Articles are highly suggested. Inquiries should be submitted to ibd.editorialoffice@jjeditorial.com.
Parameters
Manuscript body: 6,000 words (not including references, figures, and tables). Authors must request permission from the Editors to increase the length.
Tables and figures: No more than six (combined)
References: No more than 100
Supplemental data: Allowed, including tables and figures
Original Articles
Original Articles should be classified as either Basic Science or Clinical and should add to the body of knowledge of Crohn's disease and ulcerative colitis and should be in alignment with the scope of IBD. Please review IBD's mission statement for more information.
Parameters
Manuscript body: 7,000 words (not including references, figures, and tables). Authors must request permission from the Editors to increase the length.
Tables and figures: No more than seven (combined)
References: No more than 40
Supplemental data: Allowed, including tables and figures
Brief Reports
Brief Reports should be classified as either Basic Science or Clinical and should be concise communications of original research. Brief Reports should add to the body of knowledge of Crohn's disease and ulcerative colitis as well as be in alignment with the scope of IBD. Please review IBD's mission statement for more information.
Parameters
Manuscript body: 1,500 words (not including references, figures, and tables)
Tables and figures: No more than two (combined)
References: No more than 10
Abstract: An abstract should not be included
Future Directions and Methods
The Editors may designate select articles to publish in the Future Directions and Methods section. Articles published under this section will provide a deeper understanding of IBD research areas in which rapid advances and novel concepts can be made. Basic science Future Directions and Methods papers will expand our knowledge of areas that will allow novel insights to be made regarding the genetic, immunologic, microbial and environmental interactions that are the basis of the pathogenesis of inflammatory bowel diseases. Clinical Future Directions and Methods papers will allow investigators to make advances using cohort studies, multicenter registries, risk stratifications, and treatment outcomes.
Letters to the Editor
Letters in response to articles published in the Journal are welcome. All Letters should start with the phrase "To the Editors," and be written as a letter. Letters must be submitted the end of the following calendar month (e.g. by the end of July, for letters referring to articles in the June print issue). All Letters to the Editor will be published online-only and the Journal only allows for one exchange between the initial letter writer and the responding author. The Journal will also consider novel case reports written in letter format.
Parameters
Manuscript body: No more than 400 words
Tables and figures: No more than one table and one figure
References: No more than five
Supplemental data: Allowed, including tables and figures
Commentaries
Commentaries focus on timely topics related to improving the career of the IBD physician including basic research, translational and clinical research, education, and career advice. Editors’ Commentaries must be co-authored by one of IBD's Associate Editors. Invited Commentaries are invited by the Editors and must have no more than three authors.
Parameters
Manuscript body: No more than 2,500 words
Tables and figures: No more than two (combined)
References: No more than 25
Abstract: An abstract should not be included
Preparation of Manuscript
Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
Title Page
Include on the title page (a) complete manuscript title; (b) authors' full names, highest academic degrees, and affiliations; (c) name and address for correspondence, telephone number, and email address; and (d) sources of support that require acknowledgment. For both affiliations and postal addresses, please include the country.
The title page must also include disclosure of funding received for this work from any of the following organizations: National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI); and others.
Authors’ financial disclosures and conflicts of interest should be included on the title page. If there are no financial disclosures or conflicts of interest, this should be specifically noted as well.
A brief, 40-word summary of the article's main point is also required. This is separate from the article’s abstract. Summaries are not needed for Letters to the Editor.